Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1983 Aug;323(4):298-306.
doi: 10.1007/BF00512467.

Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus

Comparative Study

Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus

K Starke et al. Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug.

Abstract

Slices of the rabbit caudate nucleus were preincubated with 3H-dopamine or 3H-choline and then superfused and stimulated electrically. DiPr-5,6-ADTN reduced the stimulation-evoked overflow of tritium over the same concentration range, independently of whether slices had been preincubated with 3H-dopamine or 3H-choline, and the same was true for apomorphine, NPA and pergolide. Three other putative dopamine receptor agonists, namely 3-PPP, DPI and SKF 38393, failed to decrease the evoked overflow of tritium. Each of six antagonists--(-)-sulpiride, (+)-sulpiride, CGP 11109 A, cis-flupentixol, domperidone and corynanthine--increased the evoked overflow over the same concentration range in experiments with 3H-dopamine and in those with 3H-choline. For each of these antagonists except cis-flupentixol, and also for chlorpromazine, haloperidol and rauwolscine, the pA2 values against apomorphine obtained in 3H-dopamine and in 3H-choline experiments were closely similar. The antagonist effect of cis-flupentixol against apomorphine was not purely competitive. (-)-Sulpiride was a more potent antagonist than (+)-sulpiride, and cis-flupentixol was more potent than trans-flupentixol. This study supplements a previous one in which (+/-)-sulpiride, metoclopramide and molindone were used as antagonists. It is a functional in vitro approach to receptor characterization, as opposed to radioligand binding studies or in vivo investigations. The results show that a large number of dopamine receptor agonists and antagonists are unable to distinguish between the presynaptic, release-inhibiting dopamine autoreceptors and those postsynaptic dopamine receptors which, when activated, depress the release of acetylcholine.(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

References

    1. Eur J Pharmacol. 1982 Oct 22;84(3-4):211-4 - PubMed
    1. Arzneimittelforschung. 1967 Jan;17(1):93-7 - PubMed
    1. Eur J Pharmacol. 1981 Dec 17;76(4):345-51 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1978 Oct;305(1):27-36 - PubMed
    1. Naunyn Schmiedebergs Arch Pharmacol. 1979 Aug;308(2):127-36 - PubMed

Publication types